However, the available data suggest that IL-6, CRP, and TNF-α measurements in diabetic foot ulcers could be valuable tools for patient risk stratification, as well as predictors for lower-limb amputation and perioperative risk of morbidity and mortality. The gene discussed is IL6; the disease is diabetic foot.